Stay updated with breaking news from Orbit Discovery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Start-up SanegeneBio Inc, focused on developing novel RNAi-based medicines has entered into a Master Service Agreement with Orbit Discovery (Oxford UK), a leader in the discovery of therapeutic peptide hits. Click to read more...
Orbit Discovery Limited (Orbit), a leader in the discovery of therapeutic peptide hits, today announced it has entered into a Master Service Agreement with SanegeneBio Inc., (Sanegene), a start-up company
Orbit Discovery Limited (Orbit), a leader in the discovery of therapeutic peptide hits, today announced it has entered into a Master Service Agreement with SanegeneBio Inc.
Biopharmaceutical company Orbit Discovery has been awarded a £472,000 Smart grant by Innovate UK, to facilitate the implementation of droplet-based microfluidics for cell-based functional screening to advance the discovery of peptide therapeutic candidates. Click to read more...
Peptide technology company Orbit Discovery has announced a partnership with WuXi AppTec that will see the combination of its peptide discovery platform and experience with the Chinese organisation’s downstream capabilities as a leading global provider of R&D and manufacturing services provision for the pharmaceutical and healthcare industry. Click to read more...